Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DU26FEHZF
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,868
Award facts
- Contract value 100% obligated
- $18,868.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $18,868.32 by the Defense Logistics Agency (DLA). This delivery order, issued on November 18, 2025, with an ultimate completion date of November 19, 2025, represents one of numerous procurement actions under the company's broader Indefinite Delivery Contract (IDC) with DLA. The award carries no set-aside designation, demonstrating DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement. The delivery order falls under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy through which DLA establishes regional prime vendor contractors to supply the Department of Defense with pharmaceutical products and medical consumables.
DMS Pharmaceutical Group's IDC with DLA, designated SPE2DR and awarded November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, featuring a 30-month base period with three 30-month option periods. The company's established product portfolio encompasses branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, specialty pharmaceuticals, and medical consumables, with recent delivery orders ranging from under $100 to exceeding $115,000. Through this prime vendor arrangement, DMS Pharmaceutical Group serves as a critical pharmaceutical supplier supporting Department of Defense healthcare operations globally, fulfilling the diverse and specialized pharmaceutical requirements of military medical facilities worldwide.
Quick answers
Who was awarded contract SPE2DU26FEHZF?
SPE2DU26FEHZF was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DU26FEHZF worth?
The government has obligated $18,868 on SPE2DU26FEHZF.
Is contract SPE2DU26FEHZF an order under another contract?
Yes. SPE2DU26FEHZF is a delivery order under SPE2DU25D9415, an indefinite delivery contract.
Was contract SPE2DU26FEHZF competed?
The extent of competition for SPE2DU26FEHZF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award